Applicability of dry powder inhalers in children with CF

Anne Lexmond (London, United Kingdom), Anne Lexmond, Paul Hagedoorn, Erik Frijlink, Bart Rottier, Anne De Boer

Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring
Session: Cystic fibrosis: inflammation, microbiology, management and monitoring
Session type: Poster Discussion
Number: 4857
Disease area: Airway diseases, Paediatric lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Anne Lexmond (London, United Kingdom), Anne Lexmond, Paul Hagedoorn, Erik Frijlink, Bart Rottier, Anne De Boer. Applicability of dry powder inhalers in children with CF. Eur Respir J 2016; 48: Suppl. 60, 4857

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Use of dry powder inhalers in COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 286s
Year: 2005

Acceptability of two dry powder inhalers in 645 asthma patients
Source: Eur Respir J 2005; 26: Suppl. 49, 338s
Year: 2005

Comparison of two dry powder inhalers containing budesonide in the treatment of asthma in children
Source: Eur Respir J 2002; 20: Suppl. 38, 500s
Year: 2002

Efficacy and safety of salbutamol delivered via a novel multidose dry powder inhaler in comparison with two conventional dry powder inhalers and a pMDI in asthmatic subjects
Source: Eur Respir J 2001; 18: Suppl. 33, 50s
Year: 2001

Dose delivery characteristics of two dry powder inhalers in COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 291s
Year: 2004

In-use performance of sofotec´s dry powder inhaler
Source: Eur Respir J 2004; 24: Suppl. 48, 584s
Year: 2004

Clinical equivalence of budesonide delivered via two dry powder inhalers
Source: Eur Respir J 2005; 26: Suppl. 49, 339s
Year: 2005

Handling and patient preference of dry powder inhalers for asthma and COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 210s
Year: 2006

Do asthma patients achieve effective dosing from dry powder inhalers (DPIs)?
Source: Eur Respir J 2005; 26: Suppl. 49, 338s
Year: 2005

Equivalence testing of salbutamol dry powder inhalers by in vitro impaction
Source: Eur Respir J 2001; 18: Suppl. 33, 100s
Year: 2001

The investigation of inhalation continuous duration for dry powder inhalers in asthmatic patients
Source: Annual Congress 2012 - The best of pharmacology treatments of airway diseases: new devices and drugs
Year: 2012


Oral manifestations in asthmatic patients using metered dose inhaler and dry powder inhaler
Source: International Congress 2019 – Innovations in primary care assessment and management
Year: 2019

Improving inhalation parameters through dry powder inhalers (DPIs) after an acute asthma exacerbation
Source: Annual Congress 2012 - Trials in asthma: asthma exacerbations and severe asthma
Year: 2012


A study to evaluate the therapeutic equivalence of a new multidose budesonide dry powder inhaler with a conventional budesonide dry powder inhaler
Source: Eur Respir J 2001; 18: Suppl. 33, 156s
Year: 2001

The genuair® inhaler: a novel multidose dry powder inhaler for the delivery of various types of inhalation powder
Source: Annual Congress 2009 - New aspects of inhalation therapy
Year: 2009

Long-term preference and ease of use of a novel dry powder inhaler with budesonide in comparison to a conventional inhaler in asthmatic children
Source: Eur Respir J 2001; 18: Suppl. 33, 121s
Year: 2001

Flow-dependent performance of several formoterol dry powder inhalers (DPIs)
Source: Eur Respir J 2006; 28: Suppl. 50, 435s
Year: 2006

Reliability of inhalation therapy through a multidose dry powder inhaler
Source: Annual Congress 2007 - Respiratory issues in primary care
Year: 2007


A novel NEXT DPI® dry powder inhaler and its use in asthmatic and COPD population
Source: Annual Congress 2011 - Drug delivery and pharmacokinetics I
Year: 2011

Computerized measurements of inhalation ability with a dry powder inhaler in patients with severe COPD
Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more
Year: 2020